Vesta Healthcare
About Vesta Healthcare
Company overview
Vesta Healthcare is a healthcare technology and services company focused on delivering value-based care for high-need, chronically ill seniors through a combination of telehealth, remote monitoring, and caregiver support. Founded in 2014 as Hometeam Technologies, Inc., the company is headquartered in New York, New York, United States. Initially launched to improve in-home care by empowering caregivers, Vesta rebranded in January 2020 to emphasize its broader mission of connecting caregivers, home care agencies, and healthcare providers to enhance patient outcomes and reduce costs for health plans and risk-bearing entities. Business/Product Breakdown Vesta Healthcare offers a suite of services and technology solutions designed to support seniors aging in place. Its core offering is a 24/7 clinical support platform that integrates telehealth, remote patient monitoring, and data analytics to manage chronic conditions and prevent unnecessary hospitalizations. The platform connects professional caregivers and family members to a network of nurse practitioners and clinicians who provide real-time guidance and interventions. Vesta partners with home care agencies, Medicare Advantage plans, and other healthcare organizations, leveraging its technology, originally built on assets acquired from CareGuardian, to deliver actionable insights and coordinate care. Services include chronic care management, urgent care via telehealth, and caregiver training, all aimed at improving quality of life and reducing healthcare costs through a value-based care model. History of the company: Vesta Healthcare, originally founded in 2014 as Hometeam Technologies, Inc. (d/b/a HT Health), emerged with a focus on supporting caregivers and connecting their insights to broader care teams. In late 2018, HT Health acquired certain technology assets from CareGuardian, Inc., which had been operating under the Hometeam brand, providing personal home care services in New York and New Jersey. CareGuardian's technology became the foundation for HT Health's Hometeam Program, which aimed to enhance in-home care through caregiver engagement and telehealth capabilities. In January 2020, HT Health rebranded to Vesta Healthcare, reflecting a strategic shift to emphasize scalable, technology-driven healthcare solutions for high-need populations, particularly frail seniors. This rebranding retained the mission of supporting caregivers, both professional and family-based, while expanding its scope to partner with home care agencies, health plans, and providers. CareGuardian, meanwhile, appears to have been a precursor entity focused on direct home care delivery, with its technological innovations absorbed into Vesta's broader platform.
Keywords
Revenue
EBITDA
Valuation
| Line Item | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenues | $380 MM | $250 MM | $90 MM | $120 MM | $65 MM |
| Gross Profit | $190 MM | $125 MM | $45 MM | $60 MM | $32.50 MM |
| Net Income (Loss) | $43 MM | $25 MM | $9 MM | $12 MM | $6.50 MM |
| Line Item | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | $850 MM | $720 MM | $680 MM | $650 MM | $600 MM |
| Total Liabilities | $450 MM | $400 MM | $380 MM | $350 MM | $320 MM |
| Total Equity | $400 MM | $320 MM | $300 MM | $300 MM | $280 MM |
Ratios
M&A2024-03-15Completed
Investor Sponsors NorthBridge PE | Stake Tags 100% |
Deal Amount $120M | Is PE deal Yes |
Target Company Valuation $1.20 MM | Is deal PE backed Yes |
Techniques Acquisition of Assets, Taken Private | Total Acquired 100% |
Investor Sponsors
Deal Amount
$120M
Target Company Valuation
$1.20 MM
Techniques
Acquisition of Assets, Taken Private
Stake Tags
100%
Is PE deal
Yes
Is deal PE backed
Yes
Total Acquired
100%
Secondary Transaction2023-09-01Canceled
Investor Sponsors -- | Stake Tags Majority |
Deal Amount Undisclosed | Is PE deal No |
Target Company Valuation -- | Is deal PE backed Yes |
Techniques Secondary Sale, Management Buy-out (MBO) | Total Acquired 65% |
Investor Sponsors
--
Deal Amount
Undisclosed
Target Company Valuation
NaN
Techniques
Secondary Sale, Management Buy-out (MBO)
Stake Tags
Majority
Is PE deal
No
Is deal PE backed
Yes
Total Acquired
65%
© 2026 PrivCo Holding Inc. All rights reserved.
No AI Training or Automated Data Extraction.
Use of this page or any content or data made available by PrivCo for scraping, crawling, indexing, caching, extracting, copying, reproducing, storing, or for training or developing any artificial intelligence or machine learning system is strictly prohibited without prior written consent. All access to and use of this page and PrivCo's services are subject to the PrivCo Terms of Use: https://www.privco.com/terms-of-use. No license or right is granted by implication or otherwise.